What is the Return on Assets (ROA) of Dyne Therapeutics this year?
The Return on Assets (ROA) of Dyne Therapeutics is -1.43 undefined this year.
Dyne Therapeutics ROA 2024
Dyne Therapeutics ROA
-1.43
Ticker
DYN
ISIN
US26818M1080
WKN
A2QB6B
In 2024, Dyne Therapeutics's return on assets (ROA) was -1.43, a 160.42% increase from the -0.55 ROA in the previous year.
Dyne Therapeutics Aktienanalyse
What does Dyne Therapeutics do?
Dyne Therapeutics Inc. is a US biotechnology company specializing in the development of therapies for genetic muscle diseases (HMDs). The company was founded in 2018 and is headquartered in Waltham, Massachusetts. Dyne Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Dyne Therapeutics's Return on Assets (ROA)
Dyne Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Dyne Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Dyne Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Dyne Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Dyne Therapeutics Stock
What was the ROA of Dyne Therapeutics compared to the previous year?
The ROA of Dyne Therapeutics has increased by 160.42% compared to the previous year.
What consequences do high ROA have for investors of Dyne Therapeutics?
A high ROA is advantageous for investors of Dyne Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Dyne Therapeutics?
A low ROA can be unfavorable for investors of Dyne Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Dyne Therapeutics affect the company?
An increase in ROA of Dyne Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Dyne Therapeutics impact the company?
A reduction in the ROA of Dyne Therapeutics can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Dyne Therapeutics?
Some factors that can influence the ROA of Dyne Therapeutics include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Dyne Therapeutics important for investors?
The ROA of Dyne Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Dyne Therapeutics take to improve ROA?
To improve ROA, Dyne Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Dyne Therapeutics pay?
Over the past 12 months, Dyne Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dyne Therapeutics is expected to pay a dividend of 0 USD.
What is the dividend yield of Dyne Therapeutics?
The current dividend yield of Dyne Therapeutics is .
When does Dyne Therapeutics pay dividends?
Dyne Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Dyne Therapeutics?
Dyne Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Dyne Therapeutics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Dyne Therapeutics located?
Dyne Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Dyne Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Dyne Therapeutics from 6/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.
When did Dyne Therapeutics pay the last dividend?
The last dividend was paid out on 6/13/2024.
What was the dividend of Dyne Therapeutics in the year 2023?
In the year 2023, Dyne Therapeutics distributed 0 USD as dividends.
In which currency does Dyne Therapeutics pay out the dividend?
The dividends of Dyne Therapeutics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Dyne Therapeutics
Our stock analysis for Dyne Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dyne Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Dyne Therapeutics Revenue
- Dyne Therapeutics Net Income
- Dyne Therapeutics P/E
- Dyne Therapeutics P/S
- Dyne Therapeutics EBIT
- Dyne Therapeutics Dividend
- Dyne Therapeutics Stocks
- Dyne Therapeutics Market capitalization
- Dyne Therapeutics Debt
- Dyne Therapeutics Liabilities
- Dyne Therapeutics Equity
- Dyne Therapeutics AAQS
- Dyne Therapeutics Employees
- Dyne Therapeutics ROE
- Dyne Therapeutics ROA
- Dyne Therapeutics ROCE
